News
The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...
The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...
Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...
By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.
The Trump administration is kicking off investigations into imports of pharmaceuticals and semiconductors as part of a bid to impose tariffs on both sectors on national security grounds, notices ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...
Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...
Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Opinion: McDermott, Will & Emery's Byron Kalogerou and Meredith Cullen Schwartz say demand in the anti-obesity market and new ...
Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results